Effect of oral glycine on the clinical, spirometric and inflammatory status in subjects with cystic fibrosis: A pilot randomized trial

Patients with cystic fibrosis (CF) have airway inflammation that contributes to symptoms and to pulmonary function derangement. Current drugs used to diminish airway inflammation improve the clinical and spirometric status of patients with CF.